Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|May 23, 2012
Novel gb(3) isoforms detected in urine of fabry disease patients: a metabolomic studyC Auray-Blais, M Boutin
Journal of Inherited Metabolic Disease|September 16, 2003
Newborn urine screening programme in the province of Quebec: an update of 30 years' experienceC Auray-Blais, R Giguère, B Lemieux
Journal of Inherited Metabolic Disease|June 16, 2007
Quebec neonatal mass urinary screening programme: from micromolecules to macromoleculesC Auray-Blais, D Cyr, R Drouin
Clinical Biochemistry|April 1, 1979
Rapid thin-layer chromatographic method for the detection of urinary methylmalonic acidC Auray-Blais, R Giguère, D Paradis, et al.
Clinical Biochemistry|June 1, 1980
Diet and medications giving positive ninhydrin reactions on TLC in a newborn urinary screening programR Giguere, C Auray-Blais, P Draper, et al.
Current Medicinal Chemistry|October 25, 2012
A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkersF O Dupont, R Gagnon, M Boutin, et al.
Clinical Biochemistry|December 1, 1978
Simple and rapid system for screening and identification of reducing sugars in urineC Auray-Blais, R Giguere, P Draper, et al.
Journal of Inherited Metabolic Disease|December 16, 2006
Development of a filter paper method potentially applicable to mass and high-risk urinary screenings for Fabry diseaseC Auray-Blais, D Cyr, K Mills, et al.
Journal of Inherited Metabolic Disease|January 1, 1988
Newborn urine screening experience with over one million infants in the Quebec Network of Genetic MedicineB Lemieux, C Auray-Blais, R Giguère, et al.
Pageof 2